Cardiotropic Viruses in Cardiac Surgery Patients Without Clinical Evidence of Myocarditis or Myocarditic Sequelae
NCT ID: NCT00511160
Last Updated: 2016-10-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
120 participants
INTERVENTIONAL
2007-08-31
2010-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Primary objective:
To determine the prevalence of PVB19 and HHV6 virus genome in heart muscle biopsies of cardiac surgery patients without clinical evidence of myocarditis or myocarditic sequelae
Secondary objectives:
1. Correlation of non-invasive myocarditis screening exams (cardiac magnetic resonance, ecg, history, inflammatory markers) with biopsy results
2. Prognostic value of virus prevalence for the postoperative course
Primary hypothesis:
Patients without clinical evidence of myocarditis or myocarditic sequelae demonstrate to a significant lesser extent inflammatory activity and virus genome in their myocardium as compared to patients being clinical suspicious for myocarditis.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acute Cardiac Dysfunction in Critical Illnes
NCT05860504
Cardiac Biomarkers for the Quantification of Myocardial Damage After Cardiac Surgery
NCT06066970
Biomarkers for Postoperative Myocardial Infarction in Cardiac Surgery.
NCT02569177
Database of Tissue Samples to Understand the Inflammatory Response After Cardiac Surgery
NCT02488876
Perioperative Inflammatory Response Assessment in High-risk Patients Undergoing Noncardiac Surgery
NCT04753307
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Study arm: Cardiac surgery group, Control arm: Routine cardiology group Minimum of 100 patients included into the study arm
Inclusion criteria for the study arm:
Adult patients having cardiac surgery done under use of cardiopulmonary bypass
Data collection:
Past medical history, ecg, prior cardiovascular imaging (echo, ventriculography), cardiac magnetic resonance imaging (CMR), serologic studies, work-up of endomyocardial biopsies (histology, molecular-pathology, follow-up CMR.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
S
Study arm: Cardiac surgery group
Myocardial biopsies with TRU CUT 14 Gauge needle
Myocardial needle biopsy and right atrial appendectomy
C
Routine cardiology group
Endomyocardial biopsies
The control arm C consists of routine-workup of patients with suspected myocarditis, independent of the study arm C, but with analogous screening methods and comparable biopsy sampling
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Myocardial biopsies with TRU CUT 14 Gauge needle
Myocardial needle biopsy and right atrial appendectomy
Endomyocardial biopsies
The control arm C consists of routine-workup of patients with suspected myocarditis, independent of the study arm C, but with analogous screening methods and comparable biopsy sampling
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* presence of so far accepted parvovirus/herpesvirus associated comorbidities
* contraindications for magnetic resonance
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Udo Sechtem
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Udo Sechtem
Prof. Udo Sechtem
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Udo P Sechtem, MD
Role: STUDY_CHAIR
Head of Cardiology, Robert Bosch Krankenhaus, Stuttgart, Germany
Ulrich FW Franke, MD
Role: STUDY_DIRECTOR
Head of Cardiovascular Surgery, Robert Bosch Krankenhaus, Stuttgart, Germany
Reinhardt Kandolf, MD
Role: STUDY_DIRECTOR
Director of Institute of Molecular Pathology University Tuebingen, Germany
Hannibal Baccouche, MD
Role: PRINCIPAL_INVESTIGATOR
Department of Cardiology, Robert Bosch Krankenhaus, Stuttgart, Germany
Hardy Baumbach, MD
Role: PRINCIPAL_INVESTIGATOR
Department of Cardiovascular Surgery, Robert Bosch Krankenhaus Stuttgart, Germany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Robert Bosch Krankenhaus, Auerbachstrasse 110
Stuttgart, Baden-Wurttemberg, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RBK103
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.